Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
17%
Ph phase_2
1
17%
Ph not_applicable
2
33%
Ph phase_4
2
33%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(1)
Other(3)

Detailed Status

unknown3
Recruiting1
Completed1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 31 (16.7%)
Phase 42 (33.3%)
N/A2 (33.3%)

Trials by Status

recruiting117%
completed117%
unknown350%
active_not_recruiting117%

Recent Activity

2 active trials
Showing 5 of 6
active_not_recruitingnot_applicable

Impact Of Intermittent And Water-Only Fasting On Gene Expression And Tumor Markers In Breast Cancer

NCT07440784
completedphase_4

Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenström Macroglobulinemia

NCT02844361
recruitingphase_4

South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol

NCT05682131
unknownnot_applicable

A Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Gastric Cancer Patients

NCT05584592
unknownphase_2

Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)

NCT04055038
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07440784Not Applicable

Impact Of Intermittent And Water-Only Fasting On Gene Expression And Tumor Markers In Breast Cancer

Active Not Recruiting
NCT02844361Phase 4

Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenström Macroglobulinemia

Completed
NCT05682131Phase 4

South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol

Recruiting
NCT05584592Not Applicable

A Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Gastric Cancer Patients

Unknown
NCT04055038Phase 2

Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)

Unknown
NCT02944708Phase 3

Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6